AA, acrylamide; Acrylamide; BW, body weight; DIO1, iodothyronine deiodinase 1; DIO2, iodothyronine deiodinase 2; DIO3, iodothyronine deiodinase 3; EDCs, endocrine-disrupting chemicals; Endocrine-disrupting chemicals; HDL, high-density lipoproteins; HPT, hypothalamus-pituitary-thyroid axis; LDL, low lipoproteins; LOAEL, lowest Observed Adverse Effect Level; MCT-8, monocarboxylate transporter 8; MYH6, myosin heavy chain 6; NIS, sodium/iodide symporter; NOAEL, no Observed Adverse Effect Level; PDS, pendrin; PND, postnatal day; RfD, reference dose; T3, triiodothyronine; T4, thyroxine; TDI, tolerable daily intake; TH, thyroid hormones; THRA1, thyroid hormone receptor alpha 1; THRB2, thyroid hormone receptor beta 2; TPO, thyroid peroxidase; TRH, thyrotropin releasing hormone hormone; TRHR, thyrotropin releasing hormone receptor; TSH, thyroid hormone receptor; TSH, thyrotropin; Thyroid; Thyroid hormone metabolism